Venture Capital - Publications - Faculty & Research - Harvard Business School

Filter Results: (2,001)

Filter Results: (2,001)

Show Results For

Page 1 of 2,001 Results →

Sort by

Are you looking for?

→Search All HBS Web

February 2024 (Revised April 2024)
Case

Finberg: Corporate Venture Capital in Türkiye

By: Paul A. Gompers and Namrata Arora

In December 2021, Murat Özyeğin, Chairman of Fiba Holding, along with Ömer Mert and İhsan Elgin, engaged in discussions about the future of United Payment, a fintech company in which Finberg, a subsidiary of Fibabanka, held a 20% stake. Finberg, established in 2018 as... View Details

Keywords: Corporate Venture Capital; Technology; Return On Investment; Venture Capital; Investment; Strategy; Technological Innovation; Competition; Valuation; Acquisition; Business Startups; Information Technology Industry; Banking Industry; Middle East; North Africa; Turkey; Ukraine; Romania; Poland

Teaching Interest

Economics of Entrepreneurship and Venture Capital

Designed for Harvard College sophomores.

Course Description: Why do so many individuals choose to pursue entrepreneurship despite substantial risks? How do these entrepreneurs raise money to finance their ventures? And what is the impact of... View Details

Keywords: Entrepreneurship; Entrepreneurial Finance; Entrepreneurship And Strategy; Venture Capital

29 Apr 2008
Research Event

Venture Capital

Date: January 9-10, 2008 Faculty Chairs: Josh Lerner, William Sahlman Faculty Summary Report: Colloquium: Venture Capital What were the overall goals of the colloquium? The VC Conference is one in a series... View Details

Keywords: by Josh Lerner; Financial Services

March 2017 (Revised January 2019)
Case

Aspect Ventures

By: Paul Gompers, Danielle Li and Silpa Kovvali

Keywords: Venture Capital; Financial Services Industry; North and Central America

January 2014
Teaching Plan

MedImmune Ventures

By: Richard Hamermesh and Andrew Otazo

"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets. View Details

Keywords: MedImmune Ventures; NeuProtect; Corporate Venture Capital; Ron Laufer; Australia; Starfish Ventures; AstraZeneca; MEVE; Healthcare; Startup; Venture Capital; Business Startups; Health Industry; Australia; United States

2023
Working Paper

Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers

By: Ufuk Akcigit, Sina T. Ates, Josh Lerner, Richard Townsend and Yulia Zhestkova

The treatment of foreign investors is a contentious topic in U.S. entrepreneurship policy. We model a setting where foreign corporate investments in Silicon Valley may allow U.S. entrepreneurs to pursue technologies that they could not otherwise, but may also lead to... View Details

Keywords: Innovation; Corporate Venture Capital; Knowledge Spillovers; Innovation and Invention; Foreign Direct Investment; Venture Capital; Entrepreneurship; Policy; United States

October 2019 (Revised January 2020)
Case

NewView Capital and Venture Capital Secondaries

By: Shai Bernstein, Ramana Nanda and Allison Ciechanover

While still a general partner at Silicon Valley–based New Enterprise Associates (NEA), Ravi Viswanathan considered the challenges presented by evolving market dynamics in the venture capital space. Startups were staying private longer, which led to limited partners... View Details

Keywords: Venture Capital; Capital Markets; Private Equity; Strategy

February 2013
Article

Institutions and Venture Capital

By: Josh Lerner and Joacim Tag

We survey the literature on venture capital and institutions and present a case study comparing the development of the venture capital market in the United States and Sweden. Our literature survey underscores that the legal environment, financial market development,... View Details

Keywords: Venture Capital; Organizations; Taxation; Entrepreneurship; Financial Markets; United States; Sweden

April 2022
Case

Pear Venture Capital

By: Jo Tango and Alys Ferragamo

Keith Bender, Principal at Pear Venture Capital, is working over the weekend to prepare for a Monday morning investment meeting. He has three startup pitch decks in front of him, and he must choose one to recommend at the meeting. He finds that each company has its... View Details

Keywords: Seed Investing; Seed Financing; Startup; Decision Choices and Conditions; Presentations; Business Startups; Investment; Venture Capital; United States

2002
Chapter

Venture Capital

By: Josh Lerner

Keywords: Venture Capital

2008
Chapter

Venture Capital

By: Josh Lerner

Keywords: Venture Capital

2004
Chapter

Venture Capital

By: Paul Gompers and Josh Lerner

Keywords: Venture Capital

1999
Chapter

Venture Capital

By: Paul Gompers and Josh Lerner

Keywords: Venture Capital

February 2016
Article

After The Break-Up: The Relational and Reputational Consequences of Withdrawals from Venture Capital Syndicates

By: Pavel Zhelyazkov and Ranjay Gulati

Traditional research has long treated reputation as an egocentric attribute, typically described as an intangible asset directly shaped by the focal actor's track record. We argue, however, that reputation is dyadic: that an actor can have different reputations with... View Details

Keywords: Network Formation; Network Search; Venture Capital; Syndication; Networks

Find at Harvard

March 2001 (Revised February 2005)
Case

Venture Capital Vignettes

By: G. Felda Hardymon

Presents three fictionalized but realistic situations in which a venture capitalist may find himself. One situation requires crisis intervention to quell a dispute between a vice president of sales and a CEO; another poses the problem of working out the composition of... View Details

Keywords: Venture Capital; Crisis Management; Governing and Advisory Boards; Management Teams; Executive Compensation; Situation or Environment; Employee Relationship Management; Problems and Challenges; Financial Services Industry

August 2013 (Revised October 2013)
Case

MedImmune Ventures

By: Richard G. Hamermesh and David Lane

Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details

Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London

February 2014
Background Note

Raising Startup Capital

By: Jeffrey Bussgang

Entrepreneurs typically focus their full energies on business-building. But raising capital is a core part of building a valuable business. Developing expertise in raising capital is more than a necessary evil, it is a competitive weapon. Master it and you will be in a... View Details

November 2022
Course Overview Note

Launching Technology Ventures (LTV)

By: Jeffrey J. Bussgang

Keywords: Technology; Venture Capital

September 2011 (Revised August 2012)
Background Note

The Venture Capital Problem Set

By: William Sahlman, Evan W. Richardson and James McQuade

This note consists of three valuation/analysis exercises often found in venture capital financing deals. View Details

Keywords: Venture Capital; Financing and Loans; Management Analysis, Tools, and Techniques; Negotiation Deal; Valuation

2004
Book

Entrepreneurship and Venture Capital

By: Amar Bhidé

Academics and practitioners readily admit the importance of entrepreneurs for the wealth of nations. However, the relationship between the economic and social environment, entrepreneurship and value creation is not yet well understood. Moreover, at the micro-level, the... View Details

Keywords: Entrepreneur; Entrepreneurship; Venture Capital; Corporate Finance

1
2
…
100
101
→